Article Text

Download PDFPDF

Endoscopic ultrasound (EUS) and the management of pancreatic cancer
  1. Muhammad Nadeem Yousaf1,2,3,4,
  2. Fizah S Chaudhary2,3,4,
  3. Amrat Ehsan2,3,4,
  4. Alejandro L Suarez1,
  5. Thiruvengadam Muniraj1,
  6. Priya Jamidar1,
  7. Harry R Aslanian1,
  8. James J Farrell1
  1. 1Department of Medicine, Section Digestive Diseases, Yale University School of Medicine, New Haven, Connecticut, USA
  2. 2Department of Internal Medicine, MedStar Union Memorial Hospital, Baltimore, Maryland, USA
  3. 3Department of Internal Medicine, MedStar Good Samaritan Hospital, Baltimore, Maryland, USA
  4. 4Department of Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, Maryland, USA
  1. Correspondence to Dr Muhammad Nadeem Yousaf; muhammad.n.yousaf{at}medstar.net

Abstract

Pancreatic cancer is one of the leading causes of cancer-related mortality in western countries. Early diagnosis of pancreatic cancers plays a key role in the management by identification of patients who are surgical candidates. The advancement in the radiological imaging and interventional endoscopy (including endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography and endoscopic enteral stenting techniques) has a significant impact in the diagnostic evaluation, staging and treatment of pancreatic cancer. The multidisciplinary involvement of radiology, gastroenterology, medical oncology and surgical oncology is central to the management of patients with pancreatic cancers. This review aims to highlight the diagnostic and therapeutic role of EUS in the management of patients with pancreatic malignancy, especially pancreatic ductal adenocarcinoma.

  • pancreatic cancer
  • endoscopic ultrasonography
  • endoscopic procedures
  • pancreatic disorders
  • pancreato-biliary disorders
http://creativecommons.org/licenses/by-nc/4.0/

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Twitter @M_Nadeem_Yousaf

  • Contributors MNY: Manuscript writing and overall data collection. FSC, AE, ALS, TM, PJ andHRA: Review of manuscript and data and proofreading. JF: Manuscript supervision.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Data availability statement Data are available in a public, open access repository. This is a review article and all data are available online.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.